DK118682A - Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf - Google Patents

Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK118682A
DK118682A DK118682A DK118682A DK118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A DK 118682 A DK118682 A DK 118682A
Authority
DK
Denmark
Prior art keywords
anigiotropines
leucocytes
procedures
producing
tissue
Prior art date
Application number
DK118682A
Other languages
English (en)
Inventor
J H Wissler
W Schaper
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of DK118682A publication Critical patent/DK118682A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK118682A 1981-03-18 1982-03-17 Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf DK118682A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3110560A DE3110560A1 (de) 1981-03-18 1981-03-18 "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"

Publications (1)

Publication Number Publication Date
DK118682A true DK118682A (da) 1982-09-19

Family

ID=6127640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118682A DK118682A (da) 1981-03-18 1982-03-17 Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf

Country Status (8)

Country Link
US (1) US4465669A (da)
EP (1) EP0061138B1 (da)
JP (1) JPS57206621A (da)
AT (1) ATE17858T1 (da)
AU (1) AU550434B2 (da)
CA (1) CA1188244A (da)
DE (2) DE3110560A1 (da)
DK (1) DK118682A (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
GB2248777B (en) * 1984-11-29 1993-06-30 Curatech Inc Wound healing agents comprising platelet-derived growth and angiogenesis factors
US4727137A (en) * 1985-04-17 1988-02-23 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
EP0248088A4 (en) * 1985-11-22 1988-05-03 Teijin Ltd VASCULARIZATION FACTOR AND MANUFACTURING.
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
US4994559A (en) * 1985-12-17 1991-02-19 Synergen, Inc. Human basic fibroblast growth factor
EP0226181B1 (en) * 1985-12-17 1994-06-15 Synergen, Inc. Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
US4853219A (en) * 1987-08-06 1989-08-01 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6395883B1 (en) * 1991-03-11 2002-05-28 Curis, Inc. Soluble morphogenic protein complex compositions of matter
US5494808A (en) * 1994-09-15 1996-02-27 Merck & Co., Inc. Defined medium OMPC fermentation process
AU734312B2 (en) 1996-03-22 2001-06-07 General Hospital Corporation, The Administration of polypeptide growth factors following central nervous system ischemia or trauma
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
DE19810998C1 (de) * 1998-03-13 1999-08-26 Fraunhofer Ges Forschung Metallhaltige Ribonukleotidpolypeptide
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
US6783987B2 (en) * 1999-12-09 2004-08-31 Tsukasa Matsumoto Method for obtaining components from cultured leucocyte
CA2397707A1 (en) * 2000-01-07 2001-07-19 Susan S. Percival Compositions for enhancing the immune response
AUPR177300A0 (en) * 2000-11-29 2000-12-21 Centre For Molecular Biology And Medicine Therapeutic methods
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
EP1890820A4 (en) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc SYSTEMS AND METHOD FOR PRODUCING MEMBRANES
ES2764222T3 (es) * 2006-09-08 2020-06-02 Wyeth Llc Lavado con arginina en la purificación de proteínas mediante el uso de cromatografía de afinidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2722769C3 (de) * 1977-05-20 1981-08-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung von Fibrinogen
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture

Also Published As

Publication number Publication date
AU550434B2 (en) 1986-03-20
EP0061138B1 (en) 1986-02-05
JPS57206621A (en) 1982-12-18
DE3268915D1 (en) 1986-03-20
ATE17858T1 (de) 1986-02-15
DE3110560A1 (de) 1982-10-14
EP0061138A3 (en) 1983-09-07
EP0061138A2 (en) 1982-09-29
AU8163382A (en) 1982-09-23
US4465669A (en) 1984-08-14
CA1188244A (en) 1985-06-04

Similar Documents

Publication Publication Date Title
DK118682A (da) Anigiotropiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
AU578050B2 (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
AU2815589A (en) Method for the delivery of genetic material across the blood brain barrier
NO820090L (no) Fremgangsmaate for fremstilling og behandling av renninderivater
FI92258B (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
AU550626B2 (en) Chemokinesins and chemotaxins of leucocytes and inflamed tissues
ES2144391T3 (es) Derivados de alcoxi-4(1h)-piridona, sus procedimientos de preparacion y su utilizacion como medicamentos.
IL81370A (en) Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
FI885031A (fi) Vaextregulator av blodplaettetyp.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
DK118882A (da) Mitogener fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
DK118782A (da) Kemorecruitiner fra leucocyter og inflammationsvaev samt fremgangsmaade til fremstilling deraf
EP0607593A2 (de) Verfahren zur Gewinnnung von Zellkulturen mit erhöhtem Gehalt an körpereigenen Zytokinen
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
SE8105340L (sv) Nya 4-karbamoyloxioxazafosforiner samt forfarande for framstellning derav
FR2492384B1 (fr) Procede de preparation de nouveaux composes cytostatiques et compositions pharmaceutiques les contenant
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment